CytomX Therapeutics (CTMX) PT Lowered to $12 at JPMorgan, After Model Update

August 18, 2021 3:24 PM EDT Send to a Friend

JPMorgan analyst Anupam Rama lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CytomX Therapeutics (CTMX) PT Lowered to $12 at JPMorgan, After Model Update

Member Login

Free News Feed